Office of the Commissioner of Lobbying of Canada Office of the Commissioner of Lobbying of Canada

Language selection

Registry of Lobbyists

Advanced Registry Search Results

Search History (9)

Search Criteria

  1. DPOH name: CHAUHAN, BOBBY
Share this search Create an alert
Start over
Modify criteria

Refine registrations results by

Refine monthly communication reports results by

Type Subject matter of the communication
Government institution of the DPOH

If you would like to view a summary of the last 12 months for a lobbying activity, use the 12-Month Lobbying Activity Search

Monthly communication reports (13)
Results: 1-13 | Export
  1. Eli Lilly Canada Inc.
    Type: In-house Corporation
    Occurred: 2024-06-06
    Posted: 2024-07-15
    Designated public office holders:
    • Michelle Boudreau, Executive Director | Health Canada (HC)
    • Bobby Chauhan, Director | Health Canada (HC)
    • Daniel MacDonald, Director General, Drugs for Rare Diseases, Strategic Policy Branch | Health Canada (HC)
    Subject matters:
    • Health
      •
  2. Heart and Stroke Foundation of Canada / Fondation des maladies du coeur et de l’AVC
    Type: In-house Organization
    Occurred: 2024-04-26
    Posted: 2024-05-14
    Designated public office holders:
    • Bobby Chauhan, Director, Office of Pharmaceutical Management Strategies | Health Canada (HC)
    • Margaret Sharp, Director, Office of Pharmaceutical Management Strategies | Health Canada (HC)
    • Daniel MacDonald, Director General, Drugs for Rare Diseases, Strategic Policy Branch | Health Canada (HC)
    Subject matters:
    • Health
      •
  3. Heart and Stroke Foundation of Canada / Fondation des maladies du coeur et de l’AVC
    Type: In-house Organization
    Occurred: 2024-02-16
    Posted: 2024-03-14
    Designated public office holders:
    • Jennifer Boutin, Acting Director, Canada Drug Agency Transition Office | Health Canada (HC)
    • Bobby Chauhan, Director, Office of Pharmaceutical Management Strategies | Health Canada (HC)
    • Andrew Taylor, Director for Research, Policy & Data, Office of Pharmaceutical Management Strategies | Health Canada (HC)
    Subject matters:
    • Health
      •
  4. CANADIAN CANCER SOCIETY / Société canadienne du cancer
    Type: In-house Organization
    Occurred: 2024-02-16
    Posted: 2024-03-15
    Designated public office holders:
    • Margaret Sharp, Director, Office of Pharmaceutical, Management Strategies | Health Canada (HC)
    • Daniel MacDonald, Director General, Drugs for Rare Diseases, Strategic Policy Branch | Health Canada (HC)
    • Bobby Chauhan, Director, Office of Pharmaceutical, Management Strategies | Health Canada (HC)
    Subject matters:
    • Health
      •
  5. Heart and Stroke Foundation of Canada / Fondation des maladies du coeur et de l’AVC
    Type: In-house Organization
    Occurred: 2023-09-13
    Posted: 2023-10-16
    Designated public office holders:
    • Bobby Chauhan, Director, Office of Pharmaceutical Management Strategies | Health Canada (HC)
    • Lisa Thompson, Senior Policy Advisor, Office of Pharmaceutical Management Strategies | Health Canada (HC)
    • Jessica Burnett, Senior Policy Analyst, Office of Pharmaceutical Management Strategies | Health Canada (HC)
    • Jennifer Boutin, Acting Director, Canada Drug Agency Transition Office | Health Canada (HC)
    Subject matters:
    • Health
      •
  6. Canadian Health Coalition / Coalition canadienne de la santé
    Type: In-house Organization
    Occurred: 2023-09-13
    Posted: 2023-10-04
    Designated public office holders:
    • Bobby Chauhan, Director, Office of Pharmaceutical Management Strategies | Health Canada (HC)
    Subject matters:
    • Health
      •
  7. Heart and Stroke Foundation of Canada / Fondation des maladies du coeur et de l’AVC
    Type: In-house Organization
    Occurred: 2023-05-26
    Posted: 2023-06-15
    Designated public office holders:
    • Bobby Chauhan, Director, Office of Pharmaceutical Management Strategies | Health Canada (HC)
    • Michelle Boudreau, Executive Director, Office of Pharmaceutical Management Strategies | Health Canada (HC)
    • Jennifer Boutin, Acting Director, Canada Drug Agency Transition Office | Health Canada (HC)
    • Amanda Pinke, Policy Analyst, OFFICE OF PHARMACEUTICALS MANAGEMENT STRATEGIES | Health Canada (HC)
    Subject matters:
    • Health
      •
  8. Heart and Stroke Foundation of Canada / Fondation des maladies du coeur et de l’AVC
    Type: In-house Organization
    Occurred: 2023-03-06
    Posted: 2023-04-16
    Designated public office holders:
    • Bobby Chauhan, Director, Office of Pharmaceutical Management Strategies | Health Canada (HC)
    • Jessica Burnett, Senior Policy Analyst, Office of Pharmaceutical Management Strategies | Health Canada (HC)
    • Amanda Pinke, Senior Policy Analyst, Office of Pharmaceutical Management Strategies | Health Canada (HC)
    • Lisa Thompson, Senior Policy Analyst, Office of Pharmaceutical Management Strategies | Health Canada (HC)
    • Michelle Bourdreau, Executive Director, Office of Pharmaceutical Management Strategies | Health Canada (HC)
    • Margaret Sharp, Director, Office of Pharmaceutical Management Strategies | Health Canada (HC)
    • Jennifer Boutin, Acting Director, Canada Drug Agency Transition Office | Health Canada (HC)
    Subject matters:
    • Health
      •
  9. CANADIAN CANCER SOCIETY / Société canadienne du cancer
    Type: In-house Organization
    Occurred: 2023-02-02
    Posted: 2023-03-15
    Designated public office holders:
    • Jessica Burnett, Senior Policy Analyst, Office of Pharmaceutical Management Strategies | Health Canada (HC)
    • Amanda Pinke, Policy Analyst | Health Canada (HC)
    • Bobby Chauhan, Director, Office of Pharmaceutical Management Strategies | Health Canada (HC)
    Subject matters:
    • Health
      •
  10. Heart and Stroke Foundation of Canada / Fondation des maladies du coeur et de l’AVC
    Type: In-house Organization
    Occurred: 2022-11-24
    Posted: 2022-12-15
    Designated public office holders:
    • Margaret Sharp, Director, Pharmaceutical Management Strategies | Health Canada (HC)
    • Julia Oliver, Policy Analyst, Office of Pharmaceutical Management Strategies | Health Canada (HC)
    • Bobby Chauhan, Director, Office of Pharmaceutical Management Strategies | Health Canada (HC)
    • Michelle Bourdreau, Executive Director, Office of Pharmaceutical Management Strategies | Health Canada (HC)
    • Jessica Burnett, Senior Policy Analyst, Office of Pharmaceutical Management Strategies | Health Canada (HC)
    • Jennifer Boutin, Senior Policy Analyst, Canada Drug Agency Transition Office | Health Canada (HC)
    Subject matters:
    • Health
      •
  11. Heart and Stroke Foundation of Canada / Fondation des maladies du coeur et de l’AVC
    Type: In-house Organization
    Occurred: 2022-10-06
    Posted: 2022-11-15
    Designated public office holders:
    • Jennifer Boutin, Senior Policy Analyst, Canada Drug Agency Transition Office | Health Canada (HC)
    • Brent Lawlor, Acting Director, Canada Drug Agency Transition Office | Health Canada (HC)
    • Margaret Sharp, Director - Pharmacy, Office of Pharmaceutical Management Strategies | Health Canada (HC)
    • Bobby Chauhan, Director - Engagement, Office of Pharmaceutical Management Strategies | Health Canada (HC)
    • Michelle Bourdreau, Executive Director, Office of Pharmaceutical Management Strategies | Health Canada (HC)
    Subject matters:
    • Health
      •
  12. Heart and Stroke Foundation of Canada / Fondation des maladies du coeur et de l’AVC
    Type: In-house Organization
    Occurred: 2022-06-16
    Posted: 2022-07-15
    Designated public office holders:
    • Bobby Chauhan, Acting Director | Health Canada (HC)
    • Margaret Sharp, Director | Health Canada (HC)
    • Michelle Boudreau, Executive Director, Office of Pharmaceutical Management Strategies | Health Canada (HC)
    Subject matters:
    • Health
      •
  13. Canadian Biosimilars Forum / Forum canadien des biosimilaires
    Type: Consultant
    Lobbyist: Ross Wallace, Santis Health
    Occurred: 2016-11-22
    Posted: 2016-12-15
    Designated public office holders:
    • Jian Wang, Division Chief, Health Products and Food Branch | Health Canada (HC)
    • Liz Anne Gillham-Eisen, A/Director, Health Products and Food Branch | Health Canada (HC)
    • Stephanie Hardy, Manager, Policy Unit, Health Products and Food Branch | Health Canada (HC)
    • Wallace Lauzon, Division Chief, Health Products and Food Branch | Health Canada (HC)
    • Bobby Chauhan, Senior Regulatory Officer, Health Products and Food Branch | Health Canada (HC)
    • Georgette Roy, Director, Office of Regulatory Affairs, Health Products and Food Branch | Health Canada (HC)
    • Jeffrey Skene, Division Chief, Health Products and Food Branch | Health Canada (HC)
    • Agnes Klein, Director, Health Products and Food Branch | Health Canada (HC)
    • Catherine Parker, Director General, Health Products and Food Branch | Health Canada (HC)
    • Sandra Alderdice, Regulatory Affairs Supervisor, Health Products and Food Branch | Health Canada (HC)
    • Catherine Njue, Biostatistician Advisor - Clinical Trials, Health Products and Food Branch | Health Canada (HC)
    • Anthony Ridgway, Acting Director, Health Products and Food Branch | Health Canada (HC)
    • Andrea Bedard, Policy Analyst, Health Products and Food Branch | Health Canada (HC)
    Subject matters:
    • Health
      •
Date Modified: